Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 167 Neoplasms 30 Neoplasm Metastasis 29 Brain Neoplasms 16 Breast Neoplasms, Male 15 Head and Neck Neoplasms 8 Urinary Bladder Neoplasms 7 Stomach Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Ovarian Neoplasms 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Inflammatory Breast Neoplasms 5 Glioblastoma 5 Carcinoma, Non-Small-Cell Lung 5 Esophageal Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Salivary Gland Neoplasms 3 Recurrence 3 Pancreatic Neoplasms 3 Lung Neoplasms 3 Gliosarcoma 3 Glioma 3 Gallbladder Neoplasms 3 Ependymoma 3 Carcinoma, Squamous Cell 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Osteitis Deformans 2

Interventions

Blood Specimen Collection 29 Reverse Transcriptase Polymerase Chain Reaction 7 Flow Cytometry 7 Surgical Procedures, Operative 4 Liquid Biopsy 4 cabazitaxel 3 Trastuzumab 3 Propofol 3 Carboplatin 3 Bevacizumab 3 Standard of Care 2 Spinal Puncture 2 Sevoflurane 2 Positron Emission Tomography Computed Tomography 2 Pirinitramide 2 Neoadjuvant Therapy 2 Morphine 2 Laparoscopy 2 Hematologic Tests 2 Gemcitabine 2 Folfox protocol 2 Epirubicin 2 Drug Therapy 2 Docetaxel 2 Cyclophosphamide 2 Cisplatin 2 Cetuximab 2 Capecitabine 2 Aspirin 2 Anesthesia, General 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplastic Cells, Circulating × Lapatinib × Clear all

NCT01619111 2024-06-04

DETECT III

University of Ulm

Phase 3 Completed

Breast Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡